Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Irish Journal of Medical Science (1971 -)
Literature
1.
Pearson DC et al (2002) Azathioprine for maintaining remission of Crohn’s disease. Cochrane Database Syst Rev 2:CD000067
2.
Thomas A, Lodhia N (2014) Advanced therapy for inflammatory bowel disease: a guide for the primary care physician. J Am Board Fam Med 27(3):411–420CrossRefPubMed
3.
Peyrin-Biroulet L et al (2011) Increased risk for nonmelanoma skin cancers in patients who receive thiopurines for inflammatory bowel disease. Gastroenterology 141(5):1621–1628 e1–5CrossRefPubMed
4.
Strom SS, Yamamura Y (1997) Epidemiology of nonmelanoma skin cancer. Clin Plast Surg. 24(4):627–636 (Review) PubMed
5.
6.
Hofbauer GF, Attard NR, Harwood CA, McGregor JM, Dziunycz P, Iotzova Weiss G, Straub G, Meyer R, Kamenisch Y, Berneburg M, French LE, Wüthrich RP, Karran P, Serra AL (2012) Reversal of UVA skin photosensitivity and DNA damage in kidney transplant recipients by replacing azathioprine. Am J Transplant 12(1):218–225. doi:10.​1111/​j.​1600-6143.​2011.​03751.​x CrossRefPubMed
7.
8.
9.
10.
Long MD, Kappelman MD, Pipkin CA (2011) Nonmelanoma skin cancer in inflammatory bowel disease: a review. Inflamm Bowel Dis 17(6):1423–1427CrossRefPubMed
Metadata
Title
Attitudes towards sun exposure in inflammatory bowel disease patients taking azathioprine
Authors
E. Gilhooley
A. Farrelly
C. Connolly
A. M. Tobin
Publication date
01-05-2017
Publisher
Springer London
Published in
Irish Journal of Medical Science (1971 -) / Issue 2/2017
Print ISSN: 0021-1265
Electronic ISSN: 1863-4362
DOI
https://doi.org/10.1007/s11845-016-1426-6

Other articles of this Issue 2/2017

Irish Journal of Medical Science (1971 -) 2/2017 Go to the issue

Brief Report

An analysis of inpatient dermatologic consultations at University Hospital Limerick: inadequate infrastructure leads to acute skin failure

Original Article

In vitro study of human mutL homolog 1 hypermethylation in inducing drug resistance of esophageal carcinoma

Letter to the Editor

Is it time to introduce varicella vaccine to our children?

Original Article

Radon testing in rapid access lung clinics: an opportunity for secondary prevention

Book Review

Susan Bewley (Ed.): My life as a woman and a doctor—Beulah Bewley

Original Article

A decade of domiciliary non-invasive ventilation in the west of Ireland
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits